Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.81 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.81 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.48 |
| ▸ | ACHE | P22303 | 8/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL117684 | 0.98 | — | — | |
| Fluoride SCHEMBL27694682 | 0.96 | ZDHHC20 (0.81) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| SCHEMBL773669 | 0.96 | ZDHHC20 (0.81) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| Hydrogen Sulfide SCHEMBL27823449 | 0.96 | ZDHHC20 (0.81) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| SCHEMBL14344158 | 0.96 | ZDHHC20 (0.81) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| Ammonia Solution, Strong SCHEMBL7047534 | 0.96 | ZDHHC20 (0.81) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL15846841 | 0.96 | ZDHHC20 (0.81) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| SCHEMBL3279717 | 0.94 | ZDHHC20 (0.72) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| Dimethylamine SCHEMBL2500227 | 0.94 | ZDHHC20 (0.78) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| Trimethylammonium SCHEMBL688148 | 0.92 | ZDHHC20 (0.75) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230415101-A1 | METAL-ORGANIC FRAMEWORK MATERIAL SEPARATION MEMBRANE, PREPARATION METHOD THEREFOR, AND USE THEREOF | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-12-28 | — | — | US | disclosed |
| EP-4230284-A1 | METAL-ORGANIC FRAMEWORK MATERIAL SEPARATION MEMBRANE, PREPARATION METHOD THEREFOR, AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2023-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230415101-A1 | METAL-ORGANIC FRAMEWORK MATERIAL SEPARATION MEMBRANE, PREPARATION METHOD THEREFOR, AND USE THEREOF | WASF2, SLC39A11, CYP4F11 | ZDHHC20 3605/4885ZDHHC2 2598/4885TSHR 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.